White Paper
Supporting Evidence Generation of Indirect Benefits and Risks for Medical Products Used for Infectious Diseases
Brian Canter, Nancy Allen LaPointe, Sabine Sussman, Mark McClellan
2025
Read MoreWhite Paper
Integrating Indirect Health Benefits into Biomedical Policy: Key Reforms for Federal Agencies to Reduce Disease Transmission
Sabine Sussman, Brian Canter, Mark McClellan
2025
Read MoreComment Letter
Comment Letter on CMS Proposed Guidance Document: Study Protocols That Use Real-world Data
Hannah Graunke, Beena Bhuiyan Khan
2025
Read MoreWhite Paper
Operational Tools and Best Practices to Support Electronic Health Record-Sourced Data Quality, Relevance, and Reliability at the Data Accrual Phase
Matt D'Ambrosio, Patrick Rodriguez, Nora Emmott, Rachele Hendricks-Sturrup
2025
Read More